title: [Assessment of the use of aminoglycosides at a pediatrics hospital].
abstract: METHODS
  Three surveys were successively carried out regarding aminoglycoside use: one analysis of amikacine prescriptions in the most prescribing clinical wards and two surveys among nurses and physicians respectively on prescribing, administering and monitoring aminoglycosides.
  
  
  RESULTS
  On 43 amikacine prescriptions analyzed in a month, one daily dose infusion in 30 minutes was observed in most of the patients (70%), doses and indications matched most often the official license. Half of patients treated for more than five days had no drug level monitoring. Sample collection by nurses was very erratic making results obtained not interpretable.
  
  
  CONCLUSIONS
  Subsequently, guidelines regarding aminoglycoside use were designed by the interest group, approved by the drug committee and sent to all hospital prescribers and nurses.
authors.affiliation: Service de santé publique, hôpital Robert-Debré, 48, boulevard Sérurier, 75019 Paris, France.
authors.forename: S
authors.initials: S
authors.lastname: Micard
authors.forename: J
authors.initials: J
authors.lastname: Bloch
authors.forename: Y
authors.initials: Y
authors.lastname: Aujard
authors.forename: E
authors.initials: E
authors.lastname: Bingen
authors.forename: E
authors.initials: E
authors.lastname: Jacqz-Aigrain
authors.forename: F
authors.initials: F
authors.lastname: Brion
mesh_terms: D000293:Adolescent; D000583:Amikacin / Q000627:therapeutic use*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D004363:Drug Utilization / Q000706:statistics & numerical data; D006776:Hospitals, Pediatric; D006801:Humans; D007223:Infant; D011446:Prospective Studies
chemical_list: D000900:Anti-Bacterial Agents; D000583:Amikacin